Showing posts with label Reckitt. Show all posts
Showing posts with label Reckitt. Show all posts

Reckitt Benckiser shines again as results beat forecast

Sales in the second quarter in Europe had disappointed the market, the last time that the company reported numbers in July. However third quarter before the profit 21pc Reckitt pink 568 m £, and 7pc sales climbed to the exclusion of the oscillations of the currency.

Profit margin, which rose by 2.2 percentage points, both beat forecasts and shares have increased as much as 121 p, to close up to 32% to £ 35.57.

For the year 2010, full Strepsils throat candy manufacturer and Cillit Bang, cleansing products expected sales increase 6pc and a net profit of enterprise montée.Résultats 16pc will get extra boost of the acquisition of SSL, which makes Durex condoms and footwear Scholl.Le redemption of. 54bn £ 2 has been agreed in July and completed earlier this week.

"The third quarter of the report confirms our thesis Reckitt Benckiser continues to be a well-managed company, despite the pressures of the market," said analysts Sanford c. Bernstein.

Sales increased 18pc 481 m £ business on Reckitt developing markets, which includes Asia and South America, the third trimestre.Désodorisant Airwick and Strepsils have been among the best-selling products.Operating profits jumped 28pc 68 million from £.

In Europe, which remains the largest market for Reckitt sales, third quarter sales were flat 843 m £, with the benefit of 196 million to £ operating.Sales visibility, powder coating and washing water softeners suffered because of the low consumption in the region.

Health, personal care and air fresheners were two powerful divisions of Reckitt, with sales increasing 7pc in deux.Après purchase SSL, Reckitt get about a third of its revenue comes from the fast-growing health and personal care category, compared to rival maintenant.Unilever 27pc also expands its activities in this area.

Third quarter results of the Reckitt received his heroin replacement drug Suboxone, sales of which rose 27pc 505 million boost from £ .the drug has lost its patent United States, but no less expensive generic competitor has yet been jour.à excluding pharmaceuticals company, Reckitt expects sales 5MC 10pc increase in operating income increased this year.

The last month of Reckitt separated with its Director of finance for ten years, Colin Day and is looking for its replacement.


View the original article here

Shares of Reckitt Benckiser fall as finance leader Colin Day closes for the acquisition of SSL £ 2. 5bn

The surprise announcement of departure Colin day sent shares almost 5MC or 164 p to £ 33.86 yesterday.

Mr. Day, 55, has joined Reckitt as CFO in 2000, when the shares of the company have been commercial 810 p.Depuis, he and Chief Executive of Reckitt, Bart Becht - Executive more highly paid in FTSE 100 - have built a very profitable company, with brands such as visibility stain remover, dishwasher finish powder and Veet depilation cream.

"Reckitt probably had one of the best acts double CEO Chief financier in the FTSE 100 in the past six years", said analyst execution.

Reckitt said that Mr. Day left to pursue his roles administrator not directing advertising WPP company and the Group Engineering Amec.Mr. Day has already served as a non-exec Cadbury and easyJet, where it was once regarded as a potential candidate for the Chief Executive.

May also request a r?le.Dans President 2006 interview, he said: "finance people are cut to be, I think although administrators not exécutifs.Si I went down this road and then the ultimate ambition should be to take on a Presidency."

Mr. Day will remain on as Director funding until March 2011, in order to ensure a transfer to said douceur.Reckitt review outside of the company and in its ranks of replacement, indicating that "the succession management is an important business principle.

"The jury decided who is now a good time to appoint a successor who wish to focus on main function of Finance of the company in support of the next phase of growth of Reckitt Benckiser," stated.

Last week, Reckitt was fined £ 10.2 m for market on the sale of the Gaviscon, heartburn medicine abuse however, the company said Mr. Day departure was not linked to in any way.

Mr. Day was paid £ 1.7 m in 2009 and belonging to 424,682 actions at the end of the month of March, according to the company more recent annual report, which would be worth around £ 14.4 m.

Given that Mr. Day joined Reckitt, the company has made a number of important acquisitions later which supports SSL, Durex condoms and Scholl, footwear manufacturer for £ 2. 5bn, accepted in July.

The company purchased prescription of £ 1 93bn in 2006, Boots brands such as Nurofen analgesic cases to add and Clearasil tones crème.En December 2007 Reckitt announced that it has buy Adams respiratory therapy, owner of leading U.S. cold use Mucinex, for $2 United (£ 1 5bn).

Mr. Day has joined Reckitt of Aegis, where he was Finance Director for five years and before that he worked for De La Rue and ABB.

Reckitt is due to the results of third quarter report 2 novembre.Deuxième quarter profit increased 507 million from £ 414 million from £.


View the original article here

Reckitt Benckiser fined £ 10. 2 m for market abuse Gaviscon

Lawyers for cheaper generic alternative manufacturer Reckitt, Gaviscon Pinewood, laboratories are considering to make a claim after admitted Reckitt "reached United Kingdom and European competition law", eliminating Gaviscon Original list of NHS prescription drugs in 2005.

The OFT claimed that Reckitt withdrew Gaviscon Original when its patent had expired but before a generic name has been added to the list of NHS and Gaviscon Advance, which is still protected by patent, left on the list.

When the NHS doctors find a brand drug, their software shows a generic alternative if there is one, allowing pharmacists dispensing medicines less chers.Toutefois when typed physicians Gaviscon they found only the Advance version, so no generic alternative medicine Acidex of pinewood, was offered.

Initially said Reckitt shares are legitimate, but have now has changed his position and allowed to break the laws on competition.

"While the company believes in the time it was acting in the law, as it is always our intention, we respect the opinion of the OFT in this case and agreed to resolve" Reckitt said, adding that the offence "took place a number of years in a very complex area of the Act on competition, on which there were only more recently been clarify case."

The OFT has studied last year after a snitch Reckitt talks to the BBC and a complaint Pinewood Newsnight.


View the original article here

Powered by Blogger